DISSOLVABLE PHARMACEUTICAL IMPLANT

A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a des...

Full description

Saved in:
Bibliographic Details
Main Authors CHAFFIN, KIMBERLY, A, GALLAGHER, GENEVIEVE, L, YANG, ZHONGPING, C
Format Patent
LanguageEnglish
French
Published 07.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a desired release profile of the pharmaceutical. For example, the pharmaceutical implant may be configured to dissolve and release the pharmaceutical over a length of time between about one day and about 30 days. In some examples, the pharmaceutical implant may be implanted in the body of the patient proximate to an implantable medical device. La présente invention concerne un implant pharmaceutique qui peut comprendre un médicament et au moins un excipient. Le ou les excipients peuvent se dissoudre après implantation de l'implant pharmaceutique dans le corps du patient et libérer le médicament. Le ou les excipients peuvent être sélectionnés pour procurer un profil de libération voulu dudit médicament. Par exemple, l'implant pharmaceutique peut être conçu pour se dissoudre et libérer le médicament pendant une période comprise entre environ un jour et environ 30 jours. Dans certains exemples, l'implant pharmaceutique peut être implanté dans le corps du patient à proximité d'un dispositif médical implantable.
AbstractList A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a desired release profile of the pharmaceutical. For example, the pharmaceutical implant may be configured to dissolve and release the pharmaceutical over a length of time between about one day and about 30 days. In some examples, the pharmaceutical implant may be implanted in the body of the patient proximate to an implantable medical device. La présente invention concerne un implant pharmaceutique qui peut comprendre un médicament et au moins un excipient. Le ou les excipients peuvent se dissoudre après implantation de l'implant pharmaceutique dans le corps du patient et libérer le médicament. Le ou les excipients peuvent être sélectionnés pour procurer un profil de libération voulu dudit médicament. Par exemple, l'implant pharmaceutique peut être conçu pour se dissoudre et libérer le médicament pendant une période comprise entre environ un jour et environ 30 jours. Dans certains exemples, l'implant pharmaceutique peut être implanté dans le corps du patient à proximité d'un dispositif médical implantable.
Author GALLAGHER, GENEVIEVE, L
CHAFFIN, KIMBERLY, A
YANG, ZHONGPING, C
Author_xml – fullname: CHAFFIN, KIMBERLY, A
– fullname: GALLAGHER, GENEVIEVE, L
– fullname: YANG, ZHONGPING, C
BookMark eNrjYmDJy89L5WRQcvEMDvb3CXN08nFVCPBwDPJ1dHYNDfF0dvRR8PQN8HH0C-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhkYG5qZGlmaOhsbEqQIAuwYlSw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate IMPLANT PHARMACEUTIQUE SOLUBLE
ExternalDocumentID WO2012075296A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2012075296A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:13:40 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2012075296A13
Notes Application Number: WO2011US62902
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120607&DB=EPODOC&CC=WO&NR=2012075296A1
ParticipantIDs epo_espacenet_WO2012075296A1
PublicationCentury 2000
PublicationDate 20120607
PublicationDateYYYYMMDD 2012-06-07
PublicationDate_xml – month: 06
  year: 2012
  text: 20120607
  day: 07
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies GALLAGHER, GENEVIEVE, L
CHAFFIN, KIMBERLY, A
YANG, ZHONGPING, C
MEDTRONIC, INC
RelatedCompanies_xml – name: CHAFFIN, KIMBERLY, A
– name: YANG, ZHONGPING, C
– name: GALLAGHER, GENEVIEVE, L
– name: MEDTRONIC, INC
Score 2.8562477
Snippet A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title DISSOLVABLE PHARMACEUTICAL IMPLANT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120607&DB=EPODOC&locale=&CC=WO&NR=2012075296A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbFaJajkFkzSbTY9FMmTVPKiTWtvJY8NCFKLjfj3nY2p9tTb7g7MPmBm9tt5LMAjRTOkZ3omlf2CSUTTVCnlkQAKGeT6kOaMZvy9Iwg1b0ZeFoNFC963uTB1ndDvujgiSlSO8l7V-nr9_4hl17GVm6fsDYc-nt1kZIsNOlZUWZOpaJsjJ47syBItC3GbGE5-aZQ7GQ3ESgf8Is0r7Ttzk-elrHeNinsKhzHyW1Vn0GKrDhxb27_XOnAUNC5vbDbStzmHe3s8nUb-3DB9R4g9YxIYljNLeEUDYRzEvhEmF_DgOonlSTjZ8m9vy9dod2X9S2gj6mdXICglqjCmcQA5JCmT01wtiUKUgshFiQqqC719nK73k2_ghHfrmCfag3b1-cVu0bpW2V19KD8OGnh9
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjalDJLZik22x6KJImKanmRZvW3kKSbkCQWmzEv-_s2mpPvS07MPuAmeGbnfkW4IFiGDJzM1fK9pwpxDB0JeOVABrpFGaXFozmPN8RhIY3Ic-zzqwG75teGMET-i3IEdGiCrT3Svjr5X8SyxG1lavH_A2nPp4GSc-R1-hY01VDpbLT77lx5ES2bNuI2-Rw9Cuj_JHRQqy0RxEUcqZ9d9rnfSnL7aAyOIL9GPUtqmOosUUTGvbm77UmHATrJ28crq1vdQJ3znA8jvyp1fddKfasUWDZ7iThjAbSMIh9K0xO4X7gJran4GLp39nS12h7Z-0zqCPqZ-cgaSW6MGZwANklGVOzQi-JRrQ5UeclOqgLaO3SdLlbfAsNLwn81B-GL1dwyEWi_om2oF59frFrjLRVfiMu6AfWLXto
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DISSOLVABLE+PHARMACEUTICAL+IMPLANT&rft.inventor=CHAFFIN%2C+KIMBERLY%2C+A&rft.inventor=GALLAGHER%2C+GENEVIEVE%2C+L&rft.inventor=YANG%2C+ZHONGPING%2C+C&rft.date=2012-06-07&rft.externalDBID=A1&rft.externalDocID=WO2012075296A1